Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 13/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.50 |
| ▸ | PRNP | P04156 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13722393 | 0.82 | KDM1A (0.51) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 | |
| SCHEMBL13722237 | 0.78 | MAPT (0.56) | KDM1ATSHRLMNAALDH1A1MAPT | |
| SCHEMBL12905409 | 0.77 | PIM1 (0.57) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 | |
| SCHEMBL20215770 | 0.77 | KDM1A (0.56) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 | |
| SCHEMBL27236433 | 0.73 | KDM1A (0.49) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 | |
| SCHEMBL208025 | 0.72 | PIM1 (0.79) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 | |
| SCHEMBL7998997 | 0.71 | KDM1A (0.73) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 | |
| SCHEMBL30628542 | 0.71 | KDM1A (0.73) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 | |
| SCHEMBL31302974 | 0.71 | KDM1A (0.73) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 | |
| SCHEMBL13722046 | 0.70 | PIM1 (0.53) | KDM1ASIGMAR1CYP1A2CYP2D6SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7576201-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2009-08-18 | — | — | US | disclosed |
| US-20080167465-A1 | Electrochromic compound | FITZMAURICE DONALD | 2008-07-10 | — | — | US | disclosed |
| US-7358358-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2008-04-15 | — | — | US | disclosed |
| US-7253940-B2 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND (IE) | 2007-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167465-A1 | Electrochromic compound | KCNH2, PRDM9, H1-10 | KDM1A 217/4885SIGMAR1 2683/4885CYP1A2 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.